Agata Brys, MD
Otolaryngology/Facial Plastic Surgery · Parsippany, NJNPI 1447273487
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Sanofi at 28.5% of the total.
Across 109 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$597
- Aerin Medical Inc.$438
- GSK$256
- Novartis$128
- Optinose US, Inc.$124
- Takeda Pharmaceuticals U.S.A., Inc.$99
- plus $455 from 14 others
What the payments were for
- Food & beverage$2,097100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 34 | $597 |
| Aerin Medical Inc. | 14 | $438 |
| GSK | 16 | $256 |
| Novartis | 6 | $128 |
| Optinose US, Inc. | 8 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Stryker | 2 | $66 |
| LEO Pharma Inc. | 4 | $60 |
| AbbVie(2 entities) | 3 | $55 |
| Davol Inc. | 1 | $42 |
| CSL Behring | 2 | $42 |
| Grifols USA, LLC | 2 | $41 |
| Alk-abello, Inc | 3 | $39 |
| AstraZeneca | 2 | $32 |
| Blueprint Medicines Corporation | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Medtronic | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
| Glenmark Therapeutics Inc. | 1 | $6 |
How this compares
$2,097 in reported general payments places this provider in the 60th percentile of 36 otolaryngology/facial plastic surgery providers in New Jersey.
See all otolaryngology/facial plastic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 84 | $2,849 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 16 | $1,798 |
| Fluticasone Propionate | 89 | $1,150 |
| Fluocinolone Acetonide Oil | 15 | $435 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $195 |
| Mometasone Furoate | 16 | $192 |
| Methylprednisolone | 17 | $150 |
| Prednisone | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Parsippany
- Francis JampolParsippany$919
- Robert MignoneRobbinsville$91K
- Gabriel WongMarlton$9K
- Thomas MazzoniIselin$9K
- Sayani NiyogiIselin$6K
- Lindsay PrincerEnglewood$5K
- Arvind PrabhatShrewsbury$4K
- James LeeWestwood$4K
- Gangadhar SreepadaWayne$4K
- John HannaFlemington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.